Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156075488> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2156075488 endingPage "508" @default.
- W2156075488 startingPage "503" @default.
- W2156075488 abstract "Collagen-platelet interaction plays an important role in hemostasis and pathological thrombosis. The proposed mechanism of the interaction was the activation of platelets-->releasing of contents from granules-->aggregation. The common end point is the platelets and fibrin aggregates. Platelet glycoprotein (GP) IIb/IIIa (the alphaIIbbeta3 integrin) complexes serve as a receptor for the binding of fibrinogen to form firmed aggregates. Blockading of GP IIb/IIIa has been proposed to prevent platelet aggregation independent of the substance(s) responsible for activating the platelets. The development of various forms of GP IIb/IIIa inhibitor has resulted in the inhibition of platelet aggregation, although studies of alphaIIbbeta3 receptor function and various GP IIb/IIIa inhibitors have demonstrated the potential for these agents to produce effects on other aspects of platelet function as well as having nonplatelet effects. This study investigated platelet inhibition provided by blocking the GP IIb/IIIa complex formation by using a peptide derived from the GP IIIa molecule. The peptide inhibits both types I and III collagen-induced platelet aggregation in a dose-dependent manner. The defined peptide interferes with the formation of the GP IIb/IIIa complex by inhibiting the binding of FITC-PAC-1 onto ADP-, type I collagen-, and type III collagen-activated platelets. However, P-selectin secretion is not affected by the peptide. In addition, the peptide is not interfering with the binding of FITC-PAC-1 to platelets that were preincubated with indomethacin. Results from this study may suggest that the defined peptide is an effective agent to block the interaction of types I and III collagen with platelets." @default.
- W2156075488 created "2016-06-24" @default.
- W2156075488 creator A5080503157 @default.
- W2156075488 creator A5091517816 @default.
- W2156075488 date "2005-01-01" @default.
- W2156075488 modified "2023-10-17" @default.
- W2156075488 title "A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex" @default.
- W2156075488 cites W1251243258 @default.
- W2156075488 cites W1491490245 @default.
- W2156075488 cites W1513904594 @default.
- W2156075488 cites W1569353770 @default.
- W2156075488 cites W1860530451 @default.
- W2156075488 cites W1969670226 @default.
- W2156075488 cites W2005007281 @default.
- W2156075488 cites W2012214760 @default.
- W2156075488 cites W2012601398 @default.
- W2156075488 cites W2013417615 @default.
- W2156075488 cites W2052276663 @default.
- W2156075488 cites W2056217168 @default.
- W2156075488 cites W2057372364 @default.
- W2156075488 cites W206582864 @default.
- W2156075488 cites W2067663290 @default.
- W2156075488 cites W2152291580 @default.
- W2156075488 cites W2916860571 @default.
- W2156075488 doi "https://doi.org/10.1016/j.thromres.2004.11.010" @default.
- W2156075488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15792682" @default.
- W2156075488 hasPublicationYear "2005" @default.
- W2156075488 type Work @default.
- W2156075488 sameAs 2156075488 @default.
- W2156075488 citedByCount "4" @default.
- W2156075488 crossrefType "journal-article" @default.
- W2156075488 hasAuthorship W2156075488A5080503157 @default.
- W2156075488 hasAuthorship W2156075488A5091517816 @default.
- W2156075488 hasConcept C108625454 @default.
- W2156075488 hasConcept C12554922 @default.
- W2156075488 hasConcept C170493617 @default.
- W2156075488 hasConcept C185592680 @default.
- W2156075488 hasConcept C195687474 @default.
- W2156075488 hasConcept C203014093 @default.
- W2156075488 hasConcept C26828662 @default.
- W2156075488 hasConcept C2779036427 @default.
- W2156075488 hasConcept C2779281246 @default.
- W2156075488 hasConcept C2910542480 @default.
- W2156075488 hasConcept C3018697912 @default.
- W2156075488 hasConcept C54173615 @default.
- W2156075488 hasConcept C55493867 @default.
- W2156075488 hasConcept C86803240 @default.
- W2156075488 hasConcept C89560881 @default.
- W2156075488 hasConceptScore W2156075488C108625454 @default.
- W2156075488 hasConceptScore W2156075488C12554922 @default.
- W2156075488 hasConceptScore W2156075488C170493617 @default.
- W2156075488 hasConceptScore W2156075488C185592680 @default.
- W2156075488 hasConceptScore W2156075488C195687474 @default.
- W2156075488 hasConceptScore W2156075488C203014093 @default.
- W2156075488 hasConceptScore W2156075488C26828662 @default.
- W2156075488 hasConceptScore W2156075488C2779036427 @default.
- W2156075488 hasConceptScore W2156075488C2779281246 @default.
- W2156075488 hasConceptScore W2156075488C2910542480 @default.
- W2156075488 hasConceptScore W2156075488C3018697912 @default.
- W2156075488 hasConceptScore W2156075488C54173615 @default.
- W2156075488 hasConceptScore W2156075488C55493867 @default.
- W2156075488 hasConceptScore W2156075488C86803240 @default.
- W2156075488 hasConceptScore W2156075488C89560881 @default.
- W2156075488 hasIssue "6" @default.
- W2156075488 hasLocation W21560754881 @default.
- W2156075488 hasLocation W21560754882 @default.
- W2156075488 hasOpenAccess W2156075488 @default.
- W2156075488 hasPrimaryLocation W21560754881 @default.
- W2156075488 hasRelatedWork W2000480141 @default.
- W2156075488 hasRelatedWork W2002798709 @default.
- W2156075488 hasRelatedWork W2069851017 @default.
- W2156075488 hasRelatedWork W2110864109 @default.
- W2156075488 hasRelatedWork W2360424051 @default.
- W2156075488 hasRelatedWork W2373695773 @default.
- W2156075488 hasRelatedWork W2406402830 @default.
- W2156075488 hasRelatedWork W2411921922 @default.
- W2156075488 hasRelatedWork W2776749095 @default.
- W2156075488 hasRelatedWork W2960753849 @default.
- W2156075488 hasVolume "115" @default.
- W2156075488 isParatext "false" @default.
- W2156075488 isRetracted "false" @default.
- W2156075488 magId "2156075488" @default.
- W2156075488 workType "article" @default.